Skip to main content
Clinical Trials/NCT02951936
NCT02951936WithdrawnNot Applicable

The Utility of Regional Bioimpedance in Chronically Ventilated Patients

Rabin Medical Center0 sitesStarted: December 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Primary Endpoint
number of days ventilated

Study Overview

Brief Summary

Chronically ventilated patients will be hemodynamically measured by bioimpedance (NiCAS by NI medical ltd.) for cardiac output, Total peripheral resistance and other NICAS derived parameters.

Patients fluid balance will be planned according to these parameters and the rate of liberation from ventilator and rate of worsening renal function will be measured

Detailed Description

Patients will be divided into two groups , the study group and the control group randomly assigned by a computer program .

After obtaining written informed consent , cardiac monitoring will be carried out by means of a NiCAS patients in both groups.The physician will not be exposed to the measurement data of the patients in the control group. For the research group : Monitoring will be carried out once a day , preferably at the same time the first three days . An increase in time interval is possible in accordance with an improvement in the patient . Patients will be treated according to the protocol described in Figure 1. Also , a graphic description of the various treatment zones and the exclusion zone is presented in Figure 2 .

For the control group patients will be treated according to the usual ward protocols.

The basic rules are:

Avoiding over- drying by using parameter TBW .

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All chronically ventilated patients (ventilated for more than 14 days)
  • Age between 18-90

Exclusion Criteria

  • Non ventilated patient
  • Total body water >80%

Arms & Interventions

NiCAS treated

Experimental

Measure each patient with the NiCAS once a day If Cardiac Index < 2.9 +Total Peripheral resistance Index >3000+Mean arterial pressure >70mmHG then add vasodilators.

If Heart Rate<60 consider to reduce beta blockers dose If Cardiac Index>4.2 and Mean arterial pressure 70-100mmHG and HR >100 then add Bata Blockers If patient have low Total Body Water then reduce diuretics If patient have High Total Body Water provide diuretics

Intervention: NiCAS treated (Device)

Non NiCAS treated

Sham Comparator

Measure each patient with the NiCAS once a day Do note use the NiCAS parameters to direct treatment

Intervention: Non NiCAS treated (Device)

Outcomes

Primary Outcomes

number of days ventilated

Time Frame: 90 days

Secondary Outcomes

  • kidney function(90 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pierre Singer

Director of ICU

Rabin Medical Center

Similar Trials